Bravida Holding AB announced strong financial results for Q3 2026, with net sales exceeding SEK 7 billion, up from SEK 6.4 billion the previous year. The company achieved 9% organic growth and improved its profit margin to 6.5%, a 120 basis point increase. Order intake surged by 72%, and the order backlog rose 48%, indicating robust future business. Bravida also reported a strong balance sheet with net debt to EBITDA ratio at 1.0x, reflecting financial stability and growth potential.
Bravida Holding AB's Q3 2026 earnings report shows strong growth and financial stability. For readers following Industrials-sector stocks, here is Pluang's market snapshot as of Oct 23, 2026 18:42 WIB: out of 135 priced stocks, 45 rose and 79 fell. Notable movers include Union Pacific Corporation (UNP) at USD 293.83 with 100% sell orders, Dover Corp (DOV) at USD 198.25 with a 1.41% increase, and United Airlines Holdings Inc (UAL) at USD 100.71 with 100% buy orders.
Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...
ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...
Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...
eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...
Balchem Corporation reported strong Q3 2026 results with net sales of $290.7 million, up 8.6% year-over-year, and net earnings of $46.7 million, a 16% increase. Growth was driven by all three segments: Human Nutrition and Health, Animal Nutrition and...
